BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38637882)

  • 21. Pathogenic and Low-Frequency Variants in Children With Central Precocious Puberty.
    Neocleous V; Fanis P; Toumba M; Gorka B; Kousiappa I; Tanteles GA; Iasonides M; Nicolaides NC; Christou YP; Michailidou K; Nicolaou S; Papacostas SS; Christoforidis A; Kyriakou A; Vlachakis D; Skordis N; Phylactou LA
    Front Endocrinol (Lausanne); 2021; 12():745048. PubMed ID: 34630334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
    Fanis P; Skordis N; Phylactou LA; Neocleous V
    Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report.
    Martinelli P; Maruotti GM; Pasquali D; Paladini D; Agangi A; Rippa E; Colantuoni V; Bellastella A; Sinisi AA
    J Endocrinol Invest; 2004 Apr; 27(4):357-60. PubMed ID: 15233556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
    Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes.
    Fanis P; Skordis N; Toumba M; Picolos M; Tanteles GA; Neocleous V; Phylactou LA
    Front Endocrinol (Lausanne); 2023; 14():1156616. PubMed ID: 37324257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
    Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
    Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine profile and phenotype-genotype correlation in unrelated patients with non-classical congenital adrenal hyperplasia.
    Skordis N; Shammas C; Efstathiou E; Kaffe K; Neocleous V; Phylactou LA
    Clin Biochem; 2011 Aug; 44(12):959-63. PubMed ID: 21635882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP21A2 intronic variants causing 21-hydroxylase deficiency.
    Concolino P; Rizza R; Costella A; Carrozza C; Zuppi C; Capoluongo E
    Metabolism; 2017 Jun; 71():46-51. PubMed ID: 28521877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: An Update on Genetic Analysis of CYP21A2 Gene.
    Carvalho B; Marques CJ; Santos-Silva R; Fontoura M; Carvalho D; Carvalho F
    Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):477-481. PubMed ID: 32131114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
    BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
    Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
    Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
    Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
    Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of pediatric endocrine laboratory tests: pitfalls in steroid hormone measurements and genotyping.
    Speiser PW
    Pediatr Endocrinol Rev; 2007 Oct; 5 Suppl 1():578-83. PubMed ID: 18167467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allele-specific PCR and Next-generation sequencing based genetic screening for Congenital Adrenal Hyperplasia in India.
    Ravichandran L; Korula S; Asha HS; Varghese D; Parthiban R ; Johnson J; Ishwarya J; Shetty S; Cherian KE; Jebasingh F; Kapoor N; Pachat D; Mathai S; Simon A; Rajaratnam S; Paul TV; Thomas N; Chapla A
    Eur J Med Genet; 2021 Dec; 64(12):104369. PubMed ID: 34718183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia.
    Skordis N; Kyriakou A; Tardy V; Ioannou YS; Varvaresou A; Dracopoulou-Vabouli M; Patsalis PC; Shammas C; Neocleous V; Phylactou LA
    Horm Res Paediatr; 2011; 75(3):180-6. PubMed ID: 20838032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings.
    Globa E; Zelinska N; Shcherbak Y; Bignon-Topalovic J; Bashamboo A; MсElreavey K
    Front Endocrinol (Lausanne); 2022; 13():810782. PubMed ID: 35432193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update to 21-hydroxylase deficient congenital adrenal hyperplasia.
    Trakakis E; Basios G; Trompoukis P; Labos G; Grammatikakis I; Kassanos D
    Gynecol Endocrinol; 2010 Jan; 26(1):63-71. PubMed ID: 19499408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.
    Li SY; Ding YQ; Si YL; Ye MJ; Xu CM; Qi XP
    Front Endocrinol (Lausanne); 2020; 11():543246. PubMed ID: 33071967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
    Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
    Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.